Udaya RajBhandari: A Hidden Risk of Repeated Transfusions in β Thalassemia
Udaya RajBhandari, Associate Researcher at T.U. Lions Blood Transfusion and Research Centre, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Grande Medical Journal, adding:
“I’m pleased to share that our another case report, ‘Anti-c Alloimmunization Causing Acute Hemolytic Transfusion Reaction in a Chronically Transfused β-Thalassemia Patient: A Case Report,’ has been published in the Grande Medical Journal.
This case highlights the importance of RBC antibody screening, antibody identification, and antigen-negative blood selection, particularly in patients requiring repeated transfusions.”
Title: Anti-c Alloimmunization Associated with Acute Hemolytic Transfusion Reaction in a Chronically Transfused β-Thalassemia Patient: A Case Report
Authors: Udaya Prakash Bhandari, Sabindra Maharjan, Sunil Bhasima, Bipin Nepal
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 13:01Reza Shojaei: FDA Approval Marks Milestone for Factor XIa-Targeted Therapy
-
Nov 11, 2026, 11:35Paulus Kirchhof: Oral Anticoagulation in Atrial Fibrillation After Intracranial Hemorrhage
-
Nov 11, 2026, 11:28Arturo Cesaro: Lp(a) Lowered by 78% but Cardiovascular Outcomes Remain Unchanged
-
Nov 11, 2026, 09:40Diego Martin Rabasedas: Celebrating National Voluntary Blood Donor Day in Argentina
-
Nov 11, 2026, 09:32Nathan Connell: Can a Thrombophilic Factor VIII Variant Inform Future Hemophilia A Therapies?
-
Nov 11, 2026, 09:24Amer Zeidan: Highlights from the 2026 New England Hematologic Disease Symposium
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice